Stoptions.aiStoptions.aiStoptions.aiStoptions.aiStoptions.ai
Powered by Amora Edge
How it worksResultsPricingMeet StoptieCompareBlog
Sign inStart free trial
Stoptions.ai
Powered by Amora Edge

Algorithmic scanning across the S&P 500 & Nasdaq 100. Stock & Options trade cards in your inbox by 9:35 AM ET every trading day.

Product
  • How it works
  • The Algorithm
  • Ticker Setups
  • Pricing
  • Morning Brief
  • Results
  • Compare tools
Account
  • Sign in
  • Start free trial
  • Give a gift
  • Dashboard
  • Settings
Company
  • About
  • Contact
  • Support
  • Blog
  • Sitemap
Legal
  • Terms of service
  • Privacy policy
  • Risk disclosure
  • Unsubscribe

© 2026 Stoptions.ai · All Rights Reserved

Not financial advice. Algo-generated setups are not personalised investment advice. Options trading involves significant risk of loss — past performance does not guarantee future results.

Chat with Stoptie
Stoptions.ai›Tickers›A
Last updated: Mon May 11, 2026 · 9:31 AM ET
↻ Next update: Thu May 15, 2026 · 9:31 AM ET

A Stock and Options Trade Setup — Agilent TechnologiesA logo

NYSE · S&P 500 · Life Sciences Tools & Diagnostics · Moderate-liquidity options · Large cap · ~$23B

▲ Bullish setupHealthcareLife SciencesLow-medium risk↑ Score +6 vs last update
68
Amora Edge Score
68
Top 32% of today's scan
↑ +6 vs last update
Composite of EMA, RSI, RS vs SPY & volume · updated every 72h
63
A Win Rate
63%
7 of 11 A setups hit target in the last 6 months
Tracks completed Stoptions setups on this ticker since Jan 2026
Why we cover A

Agilent is the backbone of analytical chemistry — its chromatography, mass spectrometry, and genomics platforms are mission-critical in drug development, food safety, and environmental testing labs worldwide. After a prolonged pharma and biotech customer destocking cycle through 2024–2025, order books are recovering as lab budgets reset and GLP-1 drug manufacturing creates a new sustained instrument demand cycle. Agilent has ~60% recurring revenue from consumables and services, providing a durable earnings floor even during capex freezes. Margins have held better than peers through the downturn and are now expanding as volume returns. The combination of defensive revenue mix, recovering end-markets, and a conservative valuation (~25× forward earnings vs historical 35×) sets up a compelling mean-reversion trade. Options flow has turned notably bullish, with call skew expanding ahead of the next earnings report.

Score History & Signal Changelog

Preview data

This page is a living document — updated every 72 hours from the last scan. Each data point below represents one complete algorithmic snapshot.

Score progression across 4 updates
Solid = composite · dashed = components
Signal changelog
DateUpdateScoreDeltaKey change
Apr 27#1 Created56—Page created. Post-earnings base forming; EMA structure weak but RSI turning up.
May 3#2 Update61+550-day EMA reclaim attempt underway. Sector rotation supporting life sciences names.
May 7#3 Update65+4RS rank improving on XLV outperformance. Volume pattern shows quiet accumulation.
May 11#4 Current68+3All four signals advancing. Bullish setup confirmed — watching for earnings catalyst.

Signal Breakdown

EMA Cross
Holding
17/25
Price above 21-day EMA; 50-day EMA reclaimed last week — first time in 6 months
RSI Zone
Holding
16/25
RSI at 54 — mid-range recovery momentum, room to run before overbought
RS vs SPY
Active
18/25
Outperforming XLV sector ETF by +4.2pp over 20 days; rotation into defensive growth
Volume Surge
Holding
17/25
1.6× 20-day avg on up days vs 0.8× on down days — healthy accumulation pattern

Today's Trade Card

Setup
A $125 CALL
Expires Jun 20, 2026
Premium
$3.40
Target
+80% premium
Stop loss
-50% premium
Breakeven
$128.4
Win prob.
42%
Sizing: Risk ≤ 1% of account
Greeks
Delta
0.38
Theta
-0.06
IVR
38%
IVR class
Medium
Trade card available on Pro & Elite
Or start free trial →

Options Profile

Avg IV (30d)
24%
IVR range (52-wk)
18–55%
Put/call ratio
0.72
Avg daily vol.
4.2K contracts
Open interest
68K contracts
Next earnings
Aug 19, 2026 (est.)

Risks & Fundamentals

Every setup carries risk. Here's what could move A against you, plus the key stats that frame any position.

Beta
0.7
Market cap
~$23B
Risk level
Low-medium risk
Next earnings
Aug 19, 2026 (est.)
Key risks to monitor
  • 1.Pharma/biotech capex recovery slower than expected — second destocking leg possible
  • 2.Currency headwind: ~35% international revenue exposed to USD strength
  • 3.Competitive pressure from Bruker and Waters in high-resolution mass spectrometry
These are real risks to the long thesis, not a recommendation to short. Stoptions setups are short-dated and stop-protected; size accordingly.

A Options Setup — Frequently Asked Questions

Is A a good options trade today?+

Agilent Technologies (A) currently has an Amora Edge Score of 68/100, ranking it top 32% of today's scan. This composite score is built from four sub-signals — EMA cross, RSI zone, relative strength vs SPY, and volume surge — each scored 0–25. The current read is a bullish setup, so the algorithm is positioned bullish (calls / call debit spreads). A score above 65 typically warrants a trade card with stop and target; below that, the setup is on the watchlist but not actionable.

What is A's win rate on Stoptions.ai setups?+

A's historical win rate on closed Stoptions setups is 63%. Win rate is calculated as the percentage of past A trade cards that hit their target price before stopping out. Win rate is most meaningful once a ticker has 10+ closed trades — individual ticker rates can be noisy at smaller samples. Our portfolio-wide win rate across all closed trades is the more stable benchmark.

What strike and expiry does Stoptions.ai suggest for A?+

The strike and expiry are shown on the trade card at the top of this page when the setup is active. Stoptions.ai algorithmically selects strikes targeting delta 0.35–0.45 and expirations 30–45 days out, adjusted for current implied volatility rank (IVR). When IVR is high, the system favors call debit spreads to limit vega risk; when IVR is low, single-leg long calls are preferred. The card includes the contract symbol, mid-price entry, stop, and target.

How often is the A setup updated?+

Every 72 hours we refresh A's Amora Edge Score and trade card. The underlying scan runs daily at 9:00 AM ET (pre-market) and 9:30 AM ET (post-open), so any new signal change is reflected within one trading session. If A drops below the entry threshold or the regime shifts (e.g., SPY enters a confirmed bear), the trade card is replaced with a "no setup" notice automatically.

What does the Amora Edge Score measure for A?+

The Amora Edge Score is a 0–100 composite of four technical sub-signals applied to A: (1) EMA cross — is the 20-day above the 50-day with both trending up? (2) RSI zone — is momentum in the 50–70 sweet spot, or extended/weak? (3) Relative strength vs SPY — is A outperforming the market over 20 sessions? (4) Volume surge — is participation above the 20-day average? Each sub-signal contributes 0–25 points. A currently scores 68.

How does A compare to other Life Sciences Tools & Diagnostics setups?+

A's sector rank and percentile against other Life Sciences Tools & Diagnostics tickers we track is shown on the /tickers index — sortable by Amora Edge Score, win rate, or sector. For direct comparison, see the "Related Life Sciences Tools & Diagnostics Options Setups" panel above. When multiple tickers in the same sector are scoring 80+, the algorithm flags the cluster as a sector rotation signal and may upweight position sizing.

Educational content only — not personalized investment advice. Options carry substantial risk.

The Weekly · Free

Get a Friday recap including setups like A.

Every Friday at 4:30 PM ET — trade of the week, signals in motion, sector spotlight, methodology read. 4-minute read. Free.

No spam. One email Friday afternoon. Unsubscribe in one click.

More from Stoptions.ai
← All tickersHow the algorithm worksMorning BriefResultsPricing